FTO inhibits NLRP3-mediated pyroptosis through the suppression of β-catenin ubiquitination and degradation by decreasing the stability of CBL mRNA, contributing to the alleviation of cardiac ischemia/reperfusion injury [29]. The gene discussed is FTO; the disease is myocardial ischemia.